ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE), Fate Therapeutics (NASDAQ:FATE), Tevogen Bio Holdings (NASDAQ:TVGN) and Anika Therapeutics (NASDAQ:ANIK).
ITeos Therapeutics has a consensus price target of $37.00.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $7.87 last updated November 20, 2024 at 5:17 PM EST.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.